Report Detail

Pharma & Healthcare Global Oral Vaccines Market Growth 2019-2024

  • RnM2988979
  • |
  • 20 February, 2019
  • |
  • Global
  • |
  • 164 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
In the last several years, global market of oral vaccines developed rapidly, with an average growth rate of 6.31%. In 2017, global revenue of oral vaccines is nearly 2.01 billion USD; the actual consumption is about 2.2 billion doses.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine in 2017 is about 94%, and the proportion is in decreasing trend from 2012 to 2017.

According to this study, over the next five years the Oral Vaccines market will register a 7.0% CAGR in terms of revenue, the global market size will reach US$ 3010 million by 2024, from US$ 2010 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oral Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccines market by product type, application, key manufacturers and key regions and countries.

This study considers the Oral Vaccines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Public
Private

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Oral Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Oral Vaccines market by identifying its various subsegments.
Focuses on the key global Oral Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oral Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oral Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Oral Vaccines Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Oral Vaccines Consumption 2014-2024
        • 2.1.2 Oral Vaccines Consumption CAGR by Region
      • 2.2 Oral Vaccines Segment by Type
        • 2.2.1 Rotavirus Vaccine
        • 2.2.2 Cholera Vaccine
        • 2.2.3 Oral Polio Vaccine
        • 2.2.4 Others
      • 2.3 Oral Vaccines Consumption by Type
        • 2.3.1 Global Oral Vaccines Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Oral Vaccines Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Oral Vaccines Sale Price by Type (2014-2019)
      • 2.4 Oral Vaccines Segment by Application
        • 2.4.1 Public
        • 2.4.2 Private
      • 2.5 Oral Vaccines Consumption by Application
        • 2.5.1 Global Oral Vaccines Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Oral Vaccines Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Oral Vaccines Sale Price by Application (2014-2019)

      3 Global Oral Vaccines by Players

      • 3.1 Global Oral Vaccines Sales Market Share by Players
        • 3.1.1 Global Oral Vaccines Sales by Players (2017-2019)
        • 3.1.2 Global Oral Vaccines Sales Market Share by Players (2017-2019)
      • 3.2 Global Oral Vaccines Revenue Market Share by Players
        • 3.2.1 Global Oral Vaccines Revenue by Players (2017-2019)
        • 3.2.2 Global Oral Vaccines Revenue Market Share by Players (2017-2019)
      • 3.3 Global Oral Vaccines Sale Price by Players
      • 3.4 Global Oral Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Oral Vaccines Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Oral Vaccines Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Oral Vaccines by Regions

      • 4.1 Oral Vaccines by Regions
        • 4.1.1 Global Oral Vaccines Consumption by Regions
        • 4.1.2 Global Oral Vaccines Value by Regions
      • 4.2 Americas Oral Vaccines Consumption Growth
      • 4.3 APAC Oral Vaccines Consumption Growth
      • 4.4 Europe Oral Vaccines Consumption Growth
      • 4.5 Middle East & Africa Oral Vaccines Consumption Growth

      5 Americas

      • 5.1 Americas Oral Vaccines Consumption by Countries
        • 5.1.1 Americas Oral Vaccines Consumption by Countries (2014-2019)
        • 5.1.2 Americas Oral Vaccines Value by Countries (2014-2019)
      • 5.2 Americas Oral Vaccines Consumption by Type
      • 5.3 Americas Oral Vaccines Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Oral Vaccines Consumption by Countries
        • 6.1.1 APAC Oral Vaccines Consumption by Countries (2014-2019)
        • 6.1.2 APAC Oral Vaccines Value by Countries (2014-2019)
      • 6.2 APAC Oral Vaccines Consumption by Type
      • 6.3 APAC Oral Vaccines Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Oral Vaccines by Countries
        • 7.1.1 Europe Oral Vaccines Consumption by Countries (2014-2019)
        • 7.1.2 Europe Oral Vaccines Value by Countries (2014-2019)
      • 7.2 Europe Oral Vaccines Consumption by Type
      • 7.3 Europe Oral Vaccines Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Oral Vaccines by Countries
        • 8.1.1 Middle East & Africa Oral Vaccines Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Oral Vaccines Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Oral Vaccines Consumption by Type
      • 8.3 Middle East & Africa Oral Vaccines Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Oral Vaccines Distributors
      • 10.3 Oral Vaccines Customer

      11 Global Oral Vaccines Market Forecast

      • 11.1 Global Oral Vaccines Consumption Forecast (2019-2024)
      • 11.2 Global Oral Vaccines Forecast by Regions
        • 11.2.1 Global Oral Vaccines Forecast by Regions (2019-2024)
        • 11.2.2 Global Oral Vaccines Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Oral Vaccines Forecast by Type
      • 11.8 Global Oral Vaccines Forecast by Application

      12 Key Players Analysis

      • 12.1 Merck
        • 12.1.1 Company Details
        • 12.1.2 Oral Vaccines Product Offered
        • 12.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Merck News
      • 12.2 GSK
        • 12.2.1 Company Details
        • 12.2.2 Oral Vaccines Product Offered
        • 12.2.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 GSK News
      • 12.3 Sanofi
        • 12.3.1 Company Details
        • 12.3.2 Oral Vaccines Product Offered
        • 12.3.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Sanofi News
      • 12.4 Lanzhou Institute
        • 12.4.1 Company Details
        • 12.4.2 Oral Vaccines Product Offered
        • 12.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Lanzhou Institute News
      • 12.5 Serum Institute
        • 12.5.1 Company Details
        • 12.5.2 Oral Vaccines Product Offered
        • 12.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Serum Institute News
      • 12.6 Valneva
        • 12.6.1 Company Details
        • 12.6.2 Oral Vaccines Product Offered
        • 12.6.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Valneva News
      • 12.7 Shanghai United Cell
        • 12.7.1 Company Details
        • 12.7.2 Oral Vaccines Product Offered
        • 12.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Shanghai United Cell News
      • 12.8 Bibcol
        • 12.8.1 Company Details
        • 12.8.2 Oral Vaccines Product Offered
        • 12.8.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Bibcol News
      • 12.9 PaxVax
        • 12.9.1 Company Details
        • 12.9.2 Oral Vaccines Product Offered
        • 12.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 PaxVax News
      • 12.10 Vabiotech
        • 12.10.1 Company Details
        • 12.10.2 Oral Vaccines Product Offered
        • 12.10.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Vabiotech News
      • 12.11 Tiantan Biological
      • 12.12 EuBiologics
      • 12.13 Panacea Biotec Ltd
      • 12.14 Bio-Med
      • 12.15 Halfkin Bio-Pharmaceuticals

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Oral Vaccines . Industry analysis & Market Report on Oral Vaccines is a syndicated market report, published as Global Oral Vaccines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Oral Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,928.00
      4,392.00
      5,856.00
      3,407.46
      5,111.19
      6,814.92
      568,800.60
      853,200.90
      1,137,601.20
      305,610.00
      458,415.00
      611,220.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report